Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in an academic tertiary

Irene Schmidtmann1, Daniel Kraus2, Arndt Weinmann2

  • 1Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

RMD Open
|July 7, 2023
PubMed

Insights

The 2019 EULAR/ACR systemic lupus erythematosus (SLE) criteria are sensitive and specific for outpatients. They showed good agreement with 1997 ACR criteria, confirming their utility in clinical practice.

Area of Science:

  • Rheumatology
  • Immunology
  • Clinical Diagnostics

Background:

  • Systemic lupus erythematosus (SLE) classification requires accurate diagnostic criteria.
  • Previous criteria, such as the 1997 ACR and 2012 SLICC, have been instrumental but may require updates.
  • Evaluating new criteria in diverse patient cohorts is crucial for clinical application.

Purpose of the Study:

  • To evaluate the sensitivity and specificity of the 2019 EULAR/ACR classification criteria for SLE.
  • To compare the performance of the 2019 criteria against the 1997 ACR and 2012 SLICC criteria.
  • To assess the utility of the 2019 criteria in an outpatient academic tertiary care setting.

Main Methods:

  • A prospective and retrospective observational cohort study design was employed.
  • 3377 patients were analyzed, including those with SLE, non-SLE autoimmune-mediated rheumatic diseases (ARD), and non-ARD conditions.
  • Statistical analysis focused on sensitivity, specificity, and Youden Indexes for comparing classification criteria.

Main Results:

  • The 2019 EULAR/ACR criteria demonstrated higher sensitivity (87.0%) than the 1997 ACR criteria (81.8%).
  • Specificity was slightly lower for the 2019 criteria (98.1%) compared to the 1997 criteria (99.5%).
  • Key sensitive indicators included ANA positivity and anti-dsDNA antibodies, while specific indicators included lupus nephritis classes and low complement levels.

Conclusions:

  • The 2019 EULAR/ACR SLE classification criteria were confirmed as sensitive and specific in this independent academic medical center cohort.
  • The 2019 criteria showed very good overall agreement with the 1997 ACR criteria.
  • These findings support the clinical utility of the 2019 criteria for classifying SLE in outpatients.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
7.6K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
20
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
18